Could a vaccine prevent Alzheimer's? new trial begins
⭐️ VACCINE ⭐️
Not yet recruiting
This early-stage study tests the safety of an experimental vaccine called DUVAX in 24 healthy adults aged 40-65. The vaccine aims to train the immune system to attack two proteins linked to Alzheimer's disease. Researchers will monitor side effects and measure whether the vaccine…
Phase: PHASE1 • Sponsor: Nuravax, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 20, 2026 11:57 UTC